Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 3 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 4

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Rectal Neoplasms 4Recurrence 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Interventional × Transanal Endoscopic Surgery × Clear all
NCT03959839 2025-06-03

DSETAMIS2018

Puerta de Hierro University Hospital

Phase NA Completed
70 enrolled
Gastrointestinal

Rectal Neoplasms, Recurrence

NCT03217773 2019-09-17

ESD Versus TAMIS for Early Rectal Neoplasms

Chinese University of Hong Kong

Phase NA Unknown
114 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03431428 2018-02-13

Comparison of Short-term Efficacy and Long-term Prognosis for Reduction Surgery and Radical Resection in Almost-cCR Rectal Cancer Patients

Liaoning Cancer Hospital & Institute

Phase 3 Unknown
477 enrolled
Gastrointestinal

Rectal Neoplasms

NCT01340755 2017-09-06

Laparoscopy-Assisted Transanal Endoscopy Rectosigmoid Resection for Rectal Cancer

Massachusetts General Hospital

Phase NA Completed
5 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡